Last week it was curing bacterial lung infections and preventing implant rejection. Kamada’s latest trial of its Alpha-1 Antitrypsin (AAT) protein shows that it can halt the progression of juvenile diabetes. Remember, AAT is the active ingredient in Kamada’s Glassia , used to treat emphysema.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000799026&fid=1725